Literature DB >> 33972400

Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1.

Uroos Akber1,2, Heeji Jo1,2, Seungje Jeon1,2, Seung-Joo Yang1,2, Sunhwa Bong3, Sungsu Lim4, Yun Kyung Kim4, Zee-Yong Park3, Chul-Seung Park5,2.   

Abstract

Protein aggregation can induce explicit neurotoxic events that trigger a number of presently untreatable neurodegenerative disorders. Chaperones, on the other hand, play a neuroprotective role because of their ability to unfold and refold abnormal proteins. The progressive nature of neurotoxic events makes it important to discover endogenous factors that affect pathologic and molecular phenotypes of neurodegeneration in animal models. Here, we identified microtubule-associated protein tau, and chaperones Hsp70 (heat shock protein 70) and DNAJA1 (DJ2) as endogenous substrates of cereblon (CRBN), a substrate-recruiting subunit of cullin4-RING-E3-ligase. This recruitment results in ubiquitin-mediated degradation of tau, Hsp70, and DJ2. Knocking out CRBN enhances the chaperone activity of DJ2, resulting in decreased phosphorylation and aggregation of tau, improved association of tau with microtubules, and reduced accumulation of pathologic tau across brain. Functionally abundant DJ2 could prevent tau aggregation induced by various factors like okadaic acid and heparin. Depletion of CRBN also decreases the activity of tau-kinases including GSK3α/β, ERK, and p38. Intriguingly, we found a high expression of CRBN and low levels of DJ2 in neuronal tissues of 5XFAD and APP knock-in male mouse models of Alzheimer's disease. This implies that CRBN-mediated DJ2/Hsp70 pathway may be compromised in neurodegeneration. Being one of the primary pathogenic events, elevated CRBN can be a contributing factor for tauopathies. Our data provide a functional link between CRBN and DJ2/Hsp70 chaperone machinery in abolishing the cytotoxicity of aggregation-prone tau and suggest that Crbn -/- mice serve as an animal model of resistance against tauopathies for further exploration of the molecular mechanisms of neurodegeneration.
Copyright © 2021 the authors.

Entities:  

Keywords:  DNAJA1; cereblon; chaperone; neurodegeneration; tau phosphorylation; ubiquitin

Mesh:

Substances:

Year:  2021        PMID: 33972400      PMCID: PMC8211538          DOI: 10.1523/JNEUROSCI.2494-20.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Parkin mediates the degradation-independent ubiquitination of Hsp70.

Authors:  Darren J Moore; Andrew B West; Dustin A Dikeman; Valina L Dawson; Ted M Dawson
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

2.  The ClusPro web server for protein-protein docking.

Authors:  Dima Kozakov; David R Hall; Bing Xia; Kathryn A Porter; Dzmitry Padhorny; Christine Yueh; Dmitri Beglov; Sandor Vajda
Journal:  Nat Protoc       Date:  2017-01-12       Impact factor: 13.491

3.  Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma.

Authors:  Yuan Xiao Zhu; Esteban Braggio; Chang-Xin Shi; K Martin Kortuem; Laura A Bruins; Jessica E Schmidt; Xiu-Bao Chang; Paul Langlais; Moulun Luo; Patrick Jedlowski; Betsy LaPlant; Kristina Laumann; Rafael Fonseca; P Leif Bergsagel; Joseph Mikhael; Martha Lacy; Mia D Champion; A Keith Stewart
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

4.  Hsp70 chaperones use ATP to remodel native protein oligomers and stable aggregates by entropic pulling.

Authors:  Paolo De Los Rios; Pierre Goloubinoff
Journal:  Nat Struct Mol Biol       Date:  2016-09-06       Impact factor: 15.369

5.  Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.

Authors:  Tatsuya Hoshino; Naoya Murao; Takushi Namba; Masaya Takehara; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Takahide Matsushima; Toshiharu Suzuki; Tohru Mizushima
Journal:  J Neurosci       Date:  2011-04-06       Impact factor: 6.167

6.  Rescue of Learning and Memory Deficits in the Human Nonsyndromic Intellectual Disability Cereblon Knock-Out Mouse Model by Targeting the AMP-Activated Protein Kinase-mTORC1 Translational Pathway.

Authors:  Charlotte C Bavley; Richard C Rice; Delaney K Fischer; Amanda K Fakira; Maureen Byrne; Maria Kosovsky; Bryant K Rizzo; Dolores Del Prete; Armin Alaedini; Jose A Morón; Joseph J Higgins; Luciano D'Adamio; Anjali M Rajadhyaksha
Journal:  J Neurosci       Date:  2018-02-19       Impact factor: 6.167

Review 7.  Systematic Targeting of Protein-Protein Interactions.

Authors:  Ashley E Modell; Sarah L Blosser; Paramjit S Arora
Journal:  Trends Pharmacol Sci       Date:  2016-06-04       Impact factor: 14.819

8.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse.

Authors:  Peter V Hornbeck; Jon M Kornhauser; Sasha Tkachev; Bin Zhang; Elzbieta Skrzypek; Beth Murray; Vaughan Latham; Michael Sullivan
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

9.  A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions.

Authors:  Siân Baker; Jürgen Götz
Journal:  Acta Neuropathol Commun       Date:  2016-03-31       Impact factor: 7.801

10.  CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.

Authors:  Tianyu Song; Shenghui Liang; Jiye Liu; Tingyue Zhang; Yifei Yin; Chenlu Geng; Shaobing Gao; Yan Feng; Hao Xu; Dongqing Guo; Amanda Roberts; Yuchun Gu; Yong Cang
Journal:  PLoS Genet       Date:  2018-01-25       Impact factor: 5.917

View more
  1 in total

1.  The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity.

Authors:  Julia Ring; Jelena Tadic; Selena Ristic; Michael Poglitsch; Martina Bergmann; Nemanja Radic; Dirk Mossmann; YongTian Liang; Marta Maglione; Andrea Jerkovic; Roozbeh Hajiraissi; Marcel Hanke; Victoria Küttner; Heimo Wolinski; Andreas Zimmermann; Lana Domuz Trifunović; Leonie Mikolasch; Daiana N Moretti; Filomena Broeskamp; Julia Westermayer; Claudia Abraham; Simon Schauer; Christopher Dammbrueck; Sebastian J Hofer; Mahmoud Abdellatif; Guido Grundmeier; Guido Kroemer; Ralf J Braun; Niklas Hansen; Cornelia Sommer; Mirjana Ninkovic; Sandra Seba; Patrick Rockenfeller; Friederike-Nora Vögtle; Jörn Dengjel; Chris Meisinger; Adrian Keller; Stephan J Sigrist; Tobias Eisenberg; Frank Madeo
Journal:  EMBO Mol Med       Date:  2022-04-04       Impact factor: 14.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.